tiprankstipranks
Trending News
More News >
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT
US Market
Advertisement

EyePoint Pharmaceuticals (EYPT) Ownership - Who Owns EyePoint Pharmaceuticals?

Compare
905 Followers

EyePoint Pharmaceuticals (EYPT) Ownership Overview

0.90%19.14%0.16%10.86%68.95%
0.16% Other Institutional Investors
10.86% ETFs
68.95% Public Companies and
Individual Investors
The ownership structure of EyePoint Pharmaceuticals (EYPT) stock is a mix of institutional, retail, and individual investors. Approximately 30.16% of the company’s stock is owned by Institutional Investors, 0.90% is owned by Insiders, and 68.95% is owned by Public Companies and Individual Investors.
The ownership structure of EyePoint Pharmaceuticals (EYPT) stock is a mix of institutional, retail, and individual investors. Approximately 19.30% of the company’s stock is owned by Institutional Investors, 0.90% is owned by Insiders, and 10.86% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 19, 2025
xxxxxxxxxxxxx
$59000
May 15, 2025
xxxxxxxxxxxxx
$54450
Aug 21, 2024
xxxxxxxxxxxxx
$99750
Aug 21, 2024
xxxxxxxxxxxxx
$19997

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$186036
Mar 31, 2025
xxxxxxxxxxxxx
$2711815

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,676,513Institution5.34%37,868,084
3,523,487Institution5.12%36,291,916
3,181,818Institution4.62%32,772,725
3,087,803Institution4.49%31,804,371
2,535,166Institution3.68%26,112,210
2,207,468Institution3.21%22,736,920
1,537,274Institution2.23%15,833,922
998,780Institution1.45%10,287,434
900,536Institution1.31%9,275,521
744,683Institution1.08%7,670,235

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,523,487Institution5.12%36,291,916
3,087,803Institution4.49%31,804,371
2,207,468Institution3.21%22,736,920
998,780Institution1.45%10,287,434
900,536Institution1.31%9,275,521
737,723Institution1.07%7,598,547
675,187Institution0.98%6,954,426
358,316Institution0.52%3,690,655
196,837Institution0.29%2,027,421
168,121Institution0.24%1,731,646

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,071,168Institution3.01%19,489,691
1,538,643Institution2.24%15,848,023
1,060,396Institution1.54%9,978,326
530,912Institution0.77%5,468,394
315,673Institution0.46%2,970,483
182,994Institution0.27%1,721,974
160,976Institution0.23%1,637,126
160,976Institution0.23%1,637,126
141,524Institution0.21%1,439,299
141,524Institution0.21%1,439,299

FAQ

Who Owns EyePoint Pharmaceuticals Inc (EYPT)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 0.90% is held by insiders, and 68.95% is held by retail investors.
    What percentage of EyePoint Pharmaceuticals Inc (EYPT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.16% of EyePoint Pharmaceuticals Inc (EYPT) stock is held by institutional investors.
      What percentage of EyePoint Pharmaceuticals Inc (EYPT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 68.95% of EyePoint Pharmaceuticals Inc (EYPT) stock is held by retail investors.
        Who owns the most shares of EyePoint Pharmaceuticals Inc (EYPT)?
        Vanguard owns the most shares of EyePoint Pharmaceuticals Inc (EYPT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis